Impact of CD105 Flow-Cytometric Expression on Childhood B-Acute Lymphoblastic Leukemia.

Rasha A ElkholyMohamed H FoudaEslam E ElhawaryReem A ElkholyOla A Elshora

Published in: Journal of blood medicine (2021)

CD105 can be considered as a potential prognostic marker for the detection of response to induction therapy in childhood B-ALL, and it can serve to optimize treatment decisions.

Keyphrases

acute lymphoblastic leukemia
poor prognosis
early life
nk cells
childhood cancer
allogeneic hematopoietic stem cell transplantation
label free
climate change
replacement therapy
quantum dots